{
  "table_name": "bio_component_sequences_30",
  "table_fullname": "bigquery-public-data.ebi_chembl.bio_component_sequences_30",
  "column_names": [
    "id_composant",
    "type_composant",
    "description",
    "sequence",
    "somme_md5_de_sequence",
    "id_tax",
    "organisme"
  ],
  "column_types": [
    "INT64",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "INT64",
    "STRING"
  ],
  "nested_column_names": [
    "id_composant",
    "type_composant",
    "description",
    "sequence",
    "somme_md5_de_sequence",
    "id_tax",
    "organisme"
  ],
  "nested_column_types": [
    "INT64",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "INT64",
    "STRING"
  ],
  "description": [
    "Clé primaire. Identifiant unique pour chacun des composants moléculaires des biothérapeutiques dans ChEMBL (par exemple, des chaînes d'anticorps, des protéines recombinantes, des peptides synthétiques).",
    "Type de composant moléculaire (par exemple, 'PROTEIN','DNA','RNA').",
    "Description/nom du composant moléculaire.",
    "Séquence du composant biothérapeutique.",
    "Somme de contrôle MD5 de la séquence.",
    "ID taxonomique NCBI pour l'espèce dont la séquence est issue. Peut être null pour les anticorps monoclonaux humanisés, les peptides synthétiques, etc.",
    "Nom de l'espèce dont la séquence est issue."
  ],
  "sample_rows": [
    {
      "id_composant": 6288,
      "type_composant": "PROTEIN",
      "description": "Tigatuzumab light chain",
      "sequence": "DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "somme_md5_de_sequence": "19b1591070d7f2a101ea4dbea681e46e",
      "id_tax": null,
      "organisme": null
    },
    {
      "id_composant": 6293,
      "type_composant": "PROTEIN",
      "description": "Enavatuzumab heavy chain",
      "sequence": "EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK",
      "somme_md5_de_sequence": "a54c47ebb642b0597fb99b462ee644d0",
      "id_tax": null,
      "organisme": null
    },
    {
      "id_composant": 6294,
      "type_composant": "PROTEIN",
      "description": "Enavatuzumab light chain",
      "sequence": "DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "somme_md5_de_sequence": "a758f6dd8e919ec28c3717fe0a301c5d",
      "id_tax": null,
      "organisme": null
    },
    {
      "id_composant": 6297,
      "type_composant": "PROTEIN",
      "description": "Alacizumab pegol f(ab')2 fragment",
      "sequence": "EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCVRIGEDALDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCAA",
      "somme_md5_de_sequence": "492649be3baaaa97804b4f60a77a2118",
      "id_tax": null,
      "organisme": null
    },
    {
      "id_composant": 6298,
      "type_composant": "PROTEIN",
      "description": "Alacizumab pegol light chain",
      "sequence": "DIQMTQSPSSLSASVGDRVTITCRASQDIAGSLNWLQQKPGKAIKRLIYATSSLDSGVPKRFSGSRSGSDYTLTISSLQPEDFATYYCLQYGSFPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "somme_md5_de_sequence": "6c682f17ba959b62d601da3ccaa799e0",
      "id_tax": null,
      "organisme": null
    }
  ]
}